ATHN 11: Liver Transplantation Outcomes Study

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Hemophilia A and BLiver Transplantation
Trial Locations (15)

14621

Mary M. Gooley Hemophilia Center, Inc., Rochester

15213

University of Pittsburgh, Pittsburgh

27517

Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill

43210

Ohio State University Medical Center Hemophilia Treatment Center, Columbus

46260

Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis

48202

Henry Ford Health System, Detroit

53226

Comprehensive Center for Bleeding Disorders, Milwaukee, Milwaukee

54311

Hemophilia Outreach Center Green Bay, Green Bay

55905

Mayo Comprehensive Hemophilia Center, Rochester

61614

Bleeding and Clotting Disorders Institute, Peoria

77030

Gulf States Hemophilia and Thrombophilia Center, Houston

84113

Utah Center for Bleeding and Clotting Disorders, Salt Lake City

90007

Orthopaedic Institute for Children Hemophilia Program, Los Angeles

94117

University of California, San Francisco, San Francisco

04074

Maine Hemophilia and Thrombosis Center, Scarborough

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioMarin Pharmaceutical

INDUSTRY

lead

American Thrombosis and Hemostasis Network

NETWORK